Analyze Diet
Archives of virology. Supplementum1993; 7; 111-133; doi: 10.1007/978-3-7091-9300-6_10

Biology and neurobiology of Borna disease viruses (BDV), defined by antibodies, neutralizability and their pathogenic potential.

Abstract: Borna disease viruses (BDV) isolated from more than 20 naturally infected horses, 2 sheep and a possible feline isolate were included in these studies. Most of these wild-type viruses were grown in rabbit cells. Specifically rabbit-adapted viruses establish persistent infection in immortalized cell lines of various animal species. Brain-, tissue culture-, and cell-free released viruses could all be neutralized with antibodies from naturally and experimentally infected animals (horse; hamster, rat, rabbit, mouse, and chicken), with highest titres in birds. Splenectomized rabbits, which were subsequently infected with BDV, efficiently produced high titres of neutralizing antibodies. All of the neutralizing sera and cerebrospinal fluids from infected animals inhibited tissue culture spread of BDV. Experimental infection and hyperimmunization induced antibodies directed against the major components of the soluble antigen (60, 40/38, 25 and 14.5 kD proteins). Analysis of the s-antigen complex with these sera and 6 stable monoclonal antibodies revealed that it consists of 40/38 and 25 kD proteins. Although each of these antibodies detected intracellular virus-specific structures they did not recognize outer plasma membrane antigens, showed no cross-reactivity, and had no neutralizing capacity. Unifying pathogenetic concepts of this neurotropic virus and its structural elements are discussed.
Publication Date: 1993-01-01 PubMed ID: 8219797DOI: 10.1007/978-3-7091-9300-6_10Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article examines Borna disease viruses (BDV), which tend to affect animals like horses and sheep. The study looks at how these viruses grow, the effects of antibodies from both natural and experimental infections, and whether these antibodies can neutralize the virus. The research also explores the role of various protein components in the virus structure and discusses potential paths for further understanding of the disease.

Detailed Explanation of the Research Paper

  • The study included BDV viruses sourced from naturally infected beings including more than 20 horses, 2 sheep, and a possible feline sample.
  • Most of these wild virus forms were grown in rabbit cells. The viruses that adapted to rabbit cells have been shown to be able to establish a persistent infection in immortalized cell lines from various animal species.
  • The study found that neutralizing antibodies could control all forms of the virus, whether it originated from brain tissue, tissue culture, or had been released from cells. These antibodies derived from both naturally and experimentally infected animals.

Effectiveness of Neutralizing Antibodies

  • Within these infected animals, birds showed the highest production of these effective antibodies.
  • Other useful antibodies were also produced when rabbits without spleens were infected with BDV, and these could be used to neutralize the virus effectively as well.
  • With their neutralizing effect, the antibodies present in the serum and cerebrospinal fluids of infected animals managed to inhibit the spread of BDV in tissue cultures.

Analysis of BDV Proteins and Antibodies

  • The study further analyzed how antibodies interact with the proteins that make up the antigen (a toxin or foreign substance that induces an immune response in the body, especially the production of antibodies) of the virus.
  • These antibodies were induced via an experimental infection and an enhanced immune process, and they targeted the main components—the proteins—of the virus’s soluble antigen. The most significant of these proteins were the 60, 40/38, 25 and 14.5 kD proteins.
  • Further analysis showed that the ‘s-antigen’ (soluble antigen) complex was comprised of the 40/38 and 25 kD proteins.
  • The research then provided or developed 6 stable monoclonal antibodies (antibodies derived from a single cell and all identical) for use in detecting these proteins. Although they could identify virus-specific structures located inside the cells, these antibodies did not recognize the virus’s outer plasma membrane antigens and showed no cross-reactivity, which means they didn’t react to other proteins or antigens; and they had no ability to neutralize the virus.

Future Implications of the Study

  • The study concludes by discussing unifying pathogenetic concepts of the neurotropic virus and its structural elements, which suggests potential paths for further understanding the disease and possibly developing treatments or preventive measures in the future.

Cite This Article

APA
Ludwig H, Furuya K, Bode L, Klein N, Dürrwald R, Lee DS. (1993). Biology and neurobiology of Borna disease viruses (BDV), defined by antibodies, neutralizability and their pathogenic potential. Arch Virol Suppl, 7, 111-133. https://doi.org/10.1007/978-3-7091-9300-6_10

Publication

ISSN: 0939-1983
NlmUniqueID: 9214275
Country: Austria
Language: English
Volume: 7
Pages: 111-133

Researcher Affiliations

Ludwig, H
  • Institute of Virology, Free University of Berlin, Federal Republic of Germany.
Furuya, K
    Bode, L
      Klein, N
        Dürrwald, R
          Lee, D S

            MeSH Terms

            • Animals
            • Antibodies, Viral / immunology
            • Antigens, Viral / immunology
            • Blotting, Western
            • Borna Disease / microbiology
            • Borna disease virus / immunology
            • Borna disease virus / pathogenicity
            • Borna disease virus / physiology
            • Cats
            • Cells, Cultured
            • Chickens
            • Cricetinae
            • Fluorescent Antibody Technique
            • Horses
            • Humans
            • Mice
            • Mice, Inbred BALB C
            • Neutralization Tests
            • Precipitin Tests
            • Rabbits
            • Rats
            • Sheep

            Citations

            This article has been cited 26 times.
            1. Yu X, Wang S, Wu W, Chang H, Shan P, Yang L, Zhang W, Wang X. Exploring New Mechanism of Depression from the Effects of Virus on Nerve Cells. Cells 2023 Jul 3;12(13).
              doi: 10.3390/cells12131767pubmed: 37443801google scholar: lookup
            2. Dürrwald R, Kolodziejek J, Oh DY, Herzog S, Liebermann H, Osterrieder N, Nowotny N. Vaccination against Borna Disease: Overview, Vaccine Virus Characterization and Investigation of Live and Inactivated Vaccines. Viruses 2022 Dec 2;14(12).
              doi: 10.3390/v14122706pubmed: 36560710google scholar: lookup
            3. Dietrich DE, Bode L, Spannhuth CW, Hecker H, Ludwig H, Emrich HM. Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial. BMC Pharmacol Toxicol 2020 Feb 17;21(1):12.
              doi: 10.1186/s40360-020-0391-xpubmed: 32066504google scholar: lookup
            4. Sun L, Guo Y, He P, Xu X, Zhang X, Wang H, Tang T, Zhou W, Xu P, Xie P. Genome-wide profiling of long noncoding RNA expression patterns and CeRNA analysis in mouse cortical neurons infected with different strains of borna disease virus. Genes Dis 2019 Jun;6(2):147-158.
              doi: 10.1016/j.gendis.2019.04.002pubmed: 31193942google scholar: lookup
            5. Huang H, Zhang H, Li D, Chen S, Zhou C, Li Q, He P, Fang L, Zhang Y, Li X, Zhou J, Sun L, Liu S, Guo Y, Huang Y, Xie P. Different inhibitory effects on the proliferation and apoptosis of human and laboratory Borna disease virus‑infected human neuroblastoma SH‑SY5Y cells in vitro. Mol Med Rep 2018 Jan;17(1):925-931.
              doi: 10.3892/mmr.2017.8011pubmed: 29115502google scholar: lookup
            6. Zaliunaite V, Steibliene V, Bode L, Podlipskyte A, Bunevicius R, Ludwig H. Primary psychosis and Borna disease virus infection in Lithuania: a case control study. BMC Psychiatry 2016 Nov 3;16(1):369.
              doi: 10.1186/s12888-016-1087-zpubmed: 27809822google scholar: lookup
            7. Liu S, Bode L, Zhang L, He P, Huang R, Sun L, Chen S, Zhang H, Guo Y, Zhou J, Fu Y, Zhu D, Xie P. GC-MS-Based Metabonomic Profiling Displayed Differing Effects of Borna Disease Virus Natural Strain Hu-H1 and Laboratory Strain V Infection in Rat Cortical Neurons. Int J Mol Sci 2015 Aug 17;16(8):19347-68.
              doi: 10.3390/ijms160819347pubmed: 26287181google scholar: lookup
            8. Liu X, Bode L, Zhang L, Wang X, Liu S, Zhang L, Huang R, Wang M, Yang L, Chen S, Li Q, Zhu D, Ludwig H, Xie P. Health care professionals at risk of infection with Borna disease virus - evidence from a large hospital in China (Chongqing). Virol J 2015 Mar 12;12:39.
              doi: 10.1186/s12985-015-0239-ypubmed: 25888756google scholar: lookup
            9. Zhang L, Liu S, Zhang L, You H, Huang R, Sun L, He P, Chen S, Zhang H, Xie P. Real-time qPCR identifies suitable reference genes for Borna disease virus-infected rat cortical neurons. Int J Mol Sci 2014 Nov 26;15(12):21825-39.
              doi: 10.3390/ijms151221825pubmed: 25431926google scholar: lookup
            10. Li D, Lei Y, Deng J, Zhou C, Zhang Y, Li W, Huang H, Cheng S, Zhang H, Zhang L, Huang R, Liu X, Ma L, Wang X, Li J, Xie P. Human but Not Laboratory Borna Disease Virus Inhibits Proliferation and Induces Apoptosis in Human Oligodendrocytes In Vitro. PLoS One 2013;8(6):e66623.
              doi: 10.1371/journal.pone.0066623pubmed: 23805250google scholar: lookup
            11. Huang R, Gao H, Zhang L, Jia J, Liu X, Zheng P, Ma L, Li W, Deng J, Wang X, Yang L, Wang M, Xie P. Borna disease virus infection perturbs energy metabolites and amino acids in cultured human oligodendroglia cells. PLoS One 2012;7(9):e44665.
              doi: 10.1371/journal.pone.0044665pubmed: 22970281google scholar: lookup
            12. Baur K, Rauer M, Richter K, Pagenstecher A, Götz J, Hausmann J, Staeheli P. Antiviral CD8 T cells recognize borna disease virus antigen transgenically expressed in either neurons or astrocytes. J Virol 2008 Mar;82(6):3099-108.
              doi: 10.1128/JVI.02479-07pubmed: 18184705google scholar: lookup
            13. Bode L, Ludwig H. Borna disease virus infection, a human mental-health risk. Clin Microbiol Rev 2003 Jul;16(3):534-45.
              doi: 10.1128/CMR.16.3.534-545.2003pubmed: 12857781google scholar: lookup
            14. Hausmann J, Schamel K, Staeheli P. CD8(+) T lymphocytes mediate Borna disease virus-induced immunopathology independently of perforin. J Virol 2001 Nov;75(21):10460-6.
            15. Schamel K, Staeheli P, Hausmann J. Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein. J Virol 2001 Sep;75(18):8579-88.
            16. Degiorgis MP, Berg AL, Hârd Af Segerstad C, Mörner T, Johansson M, Berg M. Borna disease in a free-ranging lynx (Lynx lynx). J Clin Microbiol 2000 Aug;38(8):3087-91.
            17. Stitz L, Nöske K, Planz O, Furrer E, Lipkin WI, Bilzer T. A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system. J Virol 1998 Nov;72(11):8884-92.
            18. Richt JA, Fürbringer T, Koch A, Pfeuffer I, Herden C, Bause-Niedrig I, Garten W. Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin. J Virol 1998 May;72(5):4528-33.
            19. Richt JA, Pfeuffer I, Christ M, Frese K, Bechter K, Herzog S. Borna disease virus infection in animals and humans. Emerg Infect Dis 1997 Jul-Sep;3(3):343-52.
              doi: 10.3201/eid0303.970311pubmed: 9284379google scholar: lookup
            20. Kishi M, Arimura Y, Ikuta K, Shoya Y, Lai PK, Kakinuma M. Sequence variability of Borna disease virus open reading frame II found in human peripheral blood mononuclear cells. J Virol 1996 Jan;70(1):635-40.
              doi: 10.1128/JVI.70.1.635-640.1996pubmed: 8523585google scholar: lookup
            21. Zimmermann W, Breter H, Rudolph M, Ludwig H. Borna disease virus: immunoelectron microscopic characterization of cell-free virus and further information about the genome. J Virol 1994 Oct;68(10):6755-8.
            22. Compans RW, Melsen LR, de la Torre JC. Virus-like particles in MDCK cells persistently infected with Borna disease virus. Virus Res 1994 Sep;33(3):261-8.
              doi: 10.1016/0168-1702(94)90107-4pubmed: 7985412google scholar: lookup
            23. de la Torre JC. Molecular biology of borna disease virus: prototype of a new group of animal viruses. J Virol 1994 Dec;68(12):7669-75.
            24. Stoyloff R, Briese T, Borchers K, Zimmermann W, Ludwig H. N-glycosylated protein(s) are important for the infectivity of Borna disease virus (BDV). Arch Virol 1994;137(3-4):405-9.
              doi: 10.1007/BF01309486pubmed: 7944960google scholar: lookup
            25. Hatalski CG, Kliche S, Stitz L, Lipkin WI. Neutralizing antibodies in Borna disease virus-infected rats. J Virol 1995 Feb;69(2):741-7.
              doi: 10.1128/JVI.69.2.741-747.1995pubmed: 7815538google scholar: lookup
            26. Lundgren AL, Lindberg R, Ludwig H, Gosztonyi G. Immunoreactivity of the central nervous system in cats with a Borna disease-like meningoencephalomyelitis (staggering disease). Acta Neuropathol 1995;90(2):184-93.
              doi: 10.1007/BF00294319pubmed: 7484095google scholar: lookup